{
  "docId": "019de077-2ede-72aa-ade1-9df6586a5c43",
  "docSlug": "07da8690ded5d079d6760889d2f598d8",
  "documentTitle": "BenevolentAI | Investor Presentation Deck | 31 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 31,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide uses a 'How we did it' process flow at the bottom to explain the underlying methodology.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-2ede-72aa-ade1-9df6586a5c43/10",
  "deckHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43",
  "deckJsonHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43.json",
  "deckAnchorHref": "/decks/019de077-2ede-72aa-ade1-9df6586a5c43#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.45,
        "x": 0.5,
        "y": 0.2
      },
      "kind": "callout",
      "text": "Benevolent Platform: Our technology and AI workflows identified a previously unknown antiviral mechanism of Baricitinib. 48hrs to identify, 9 months to emergency approval, 14 months to full approval. 38% Reduces mortality by a significant 38%. x1 Only one repurposed drug proposed by AI was approved by the FDA and recommended by WHO.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "415e1b58-6bfa-413c-ac76-a0e3832dcc64",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.92,
        "x": 0.04,
        "y": 0.75
      },
      "kind": "diagram",
      "text": "How we did it so fast: 5 years spent building data + Foundations + Connections + Platform + Insights + Way of querying",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8668a6ff-cd80-435e-967c-6128c2e3754c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.08,
        "x": 0.36,
        "y": 0.2
      },
      "kind": "image",
      "text": "Lilly",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77fd849a-707c-4198-94b4-2a68e94a57ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.35,
        "x": 0.04,
        "y": 0.33
      },
      "kind": "list",
      "text": ">4,000 clinical trials related to COVID were registered with the FDA; 485 repurposed drugs were registered for COVID clinical trials; Tens of billions was spent on developing treatments; FDA emergency use approval in Nov 2020 and full approval in May 2022",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c398b938-52de-48e6-bbd5-3301af92c200",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.04,
        "y": 0.225
      },
      "kind": "paragraph",
      "text": "Backdrop to baricitinib approval",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "97070129-73f8-4b31-9de0-892d6a2d121a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "Indication expansion - capability validation",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "732ac590-c132-44bc-8504-c7933b383fd8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before-After-Bridge",
      "slug": "before-after-bridge",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "f2213af4-defa-4c66-8318-1e7c11f40c01",
      "evidence": "The slide describes a situation where the Benevolent Platform identified a previously unknown antiviral mechanism of Baricitinib, which led to emergency approval and full approval.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "causal-chain",
      "slug": null,
      "matchId": "d7a59ed3-a2cc-4aad-9ef9-64a94360c6d9",
      "evidence": "The 'How we did it' section links sequential steps to an outcome.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}